Shengwu Liu

Shengwu Liu

Harvard University - Cambridge / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1398828
person_outline Shengwu Liu's MOST POPULAR ARTICLES
1-) Acquired Resistance to KRASG12C Inhibition in Cancer New England Journal of Medicine 384 (25), 2382-2393, 2021
2-) Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer Nature medicine 24 (5), 638-646, 2018
3-) Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells Cell Death & Differentiation 20 (3), 456-464, 2013
4-) Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 Nature medicine 23 (9), 1063-1071, 2017
5-) T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2 … Journal of Biological Chemistry 289 (25), 17647-17657, 2014